More than 4,000 abstracts will be presented on a range of topics, with special sessions on the latest in breast cancer research and genetics.

ASCO's Annual Meeting is one of the largest cancer-related conferences in the country, and over 30,000 attendees are expected this year. Previous years have seen major announcements, including 2005's breakthrough discovery that Herceptin is effective in treating early-stage breast cancer patients.

Click the links below to learn more about some of the studies being discussed during this year's conference.

News from ASCO

Vaccine Studies Offer Hope for Brain Cancer Patients
June 2, 2008
Results from two pioneering studies from Duke University Medical Center offer hope to patients with one of the deadliest forms of brain cancer.

Lung Cancer Patients: Post-Surgery Exercise Beneficial
May 27, 2008
A Duke research team has found that most patients who had surgery for non-small cell lung cancer were able to tolerate moderate exercise within a month of their operation and were less fatigued and gained greater fitness as a result. The findings will be discussed in a poster presentation.

Study Sees Link Between Vitamin D, Breast Cancer Prognosis
May 16, 2008
A new study suggests breast cancer patients might fare worse if they don't have enough vitamin D in their blood. Scientists from University of Toronto are scheduled to present their work at the meeting.